Syngene set for phase-2 trial of Covid oral tablet vaccine

Vaxart had started trials of its oral recombinant tablet vaccine in October last year. It enrolled 96 participants at four centres in the US. Participants included both-the untreated as well as previously vaccinated subjects.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7A5XPpq
via IFTTT